U.S. Software Stock News

Ducommun (DCO) has wrapped up FY 2025 with fourth quarter revenue of US$215.8 million and basic EPS of US$0.50, alongside net income of US$7.4 million. The trailing twelve month figures show revenue of US$824.7 million and a net loss of US$33.9 million tied to basic EPS of US$2.27. Over recent quarters, revenue has moved from US$197.3 million in Q4 2024 to US$215.8 million in Q4 2025, with quarterly basic EPS ranging from a loss of US$4.30 in Q3 2025 to a profit of US$0.50 in Q4 2025. For...

Shake Shack (SHAK) has wrapped up FY 2025 with fourth quarter revenue of US$400.5 million and basic EPS of US$0.29, alongside trailing 12 month revenue of US$1.4 billion and EPS of US$1.14 that sit against very large reported earnings growth of 341.7% over the past year. The company has seen trailing 12 month revenue move from US$1.25 billion at the end of Q4 2024 to US$1.45 billion by Q4 2025, while trailing EPS stepped up from US$0.26 to US$1.14 and net profit margin shifted from 0.8% to...

In February 2026, Marcus & Millichap, Inc. reported fourth-quarter 2025 revenue of US$243.95 million and net income of US$13.31 million, alongside full-year 2025 revenue of US$755.16 million and a net loss of US$1.91 million, while also disclosing that it completed a share repurchase program totaling 3,146,936 shares for US$98.00 million. These results show improved quarterly profitability and a smaller full-year loss compared with the prior year, while the completed buyback reduced the...

Are you wondering if Global Industrial still offers good value after its recent run, or if the current price already reflects the key positives for the business? The stock last closed at US$33.26, with returns of 4.3% over 7 days, 9.9% over 30 days, 13.1% year to date, 48.4% over 1 year, 32.6% over 3 years and 10.4% over 5 years. This naturally raises questions about what is now priced in. Recent coverage has focused on Global Industrial's role as a distributor of industrial and business...

Axsome Therapeutics (NasdaqGM: AXSM) has started the CLARITY Phase 3 trial of solriamfetol in major depressive disorder with excessive daytime sleepiness. The trial focuses on a group of MDD patients who experience excessive daytime sleepiness, for which no approved treatments are currently available. This study expands Axsome's clinical program into an area of unmet medical need. Axsome Therapeutics, listed on the NasdaqGM under the ticker AXSM, develops therapies for central nervous...

SPX Technologies is pursuing an acquisition-led expansion and investing heavily in capacity, including in data center infrastructure. The company recently reported record earnings that align with this repositioning of its business mix. At the same time, insider selling and shifts in institutional ownership are reshaping who holds NYSE:SPXC shares. For investors, this mix of corporate activity and ownership changes makes NYSE:SPXC a stock to watch. The shares recently closed at $231.59, with...

Papa John's International FY 2025 Earnings Snapshot Papa John's International (PZZA) closed out FY 2025 with Q4 revenue of US$498.2 million and basic EPS of US$0.24, while trailing twelve month revenue came in at about US$2.1 billion with EPS of US$0.93. The company has seen quarterly revenue move from US$530.8 million in Q4 2024 to US$498.2 million in Q4 2025, with basic EPS shifting from US$0.45 to US$0.24 over the same period, and trailing net income excluding extra items sitting at...

Magnite (MGNI) closed out FY 2025 with Q4 revenue of US$205.4 million and basic EPS of US$0.86, capped by trailing 12 month EPS of US$1.01 that sits on trailing 12 month revenue of US$714.0 million. Over the past six quarters in this dataset, revenue has moved from US$162.0 million in Q3 2024 to US$205.4 million in Q4 2025, while quarterly EPS shifted from US$0.04 to US$0.86, creating a backdrop where margins have become a central focus for investors assessing the latest print. See our full...

Rhythm Pharmaceuticals (RYTM) has wrapped up FY 2025 with Q4 revenue of US$57.3 million and a basic EPS loss of US$0.73, while trailing 12 month figures show total revenue of US$189.8 million and a basic EPS loss of US$3.11. Over recent quarters, the company has seen revenue move from US$41.8 million in Q4 2024 to US$57.3 million in Q4 2025, with basic EPS losses ranging between US$0.72 and US$0.82 per quarter. This sets up a story where revenue is building but margins remain under...

In February 2026, Jackson Financial Inc. reported fourth-quarter 2025 revenue of US$1,988 million but swung to a net loss of US$204 million, while also increasing its common dividend, declaring a preferred dividend, and completing a large share repurchase program that retired just over 40% of its shares since 2021. Despite record retail annuity sales and continued capital returns, the sharp drop in yearly net income to US$27 million and a move from earnings per share to a loss per share have...

Ultragenyx Pharmaceutical (NasdaqGS:RARE) announced that the US FDA has accepted its Biologics License Application for DTX401, a gene therapy for Glycogen Storage Disease Type Ia. The FDA has granted Priority Review to the application, signaling an expedited assessment timeline. If approved, DTX401 could become the first pharmacologic treatment option for people living with Glycogen Storage Disease Type Ia. For Ultragenyx, with a current share price of $23.04, this regulatory milestone...

If you are looking at OceanFirst Financial and wondering whether its current share price lines up with its underlying worth, you are asking the exact question this article is built to tackle. The stock last closed at US$19.04, with returns of 3.8% over the past 30 days, 6.7% year to date, and 12.8% over the past year. The 3 year and 5 year returns sit at a 5.6% decline and a 5.0% gain respectively. These share price moves sit against a backdrop of ongoing sector wide attention on US regional...

MarketAxess Holdings (NasdaqGS:MKTX) has appointed William Quan as Chief Technology Officer to lead its AI and technology modernization efforts. The company has also announced an integration with DirectBooks that is designed to streamline primary market workflows for its clients. MarketAxess runs an electronic trading platform focused on fixed income markets, connecting institutional investors and dealers in credit products. The arrival of William Quan as CTO brings a leader with experience...

Pennant Group’s FY 2025 Earnings Set Up the Next Phase of the Story The Pennant Group (PNTG) closed FY 2025 with fourth quarter revenue of US$289.3 million and basic EPS of US$0.25, capping a trailing twelve month period where revenue reached US$947.7 million and EPS came in at US$0.86. Over the past six reported quarters, the company has seen revenue move from US$188.9 million in Q4 2024 to US$289.3 million in Q4 2025, while quarterly EPS ranged between US$0.17 and US$0.25. This leaves...

Sezzle (SEZL) just wrapped up FY 2025 with Q4 revenue of US$129.9 million and basic EPS of US$1.26, rounding out a trailing twelve months that delivered US$450.3 million in revenue and EPS of US$3.93. Over the past few quarters, the company has seen revenue move from US$69.96 million in Q3 2024 to US$98.22 million in Q4 2024, then to US$104.9 million in Q1 2025 and US$129.9 million in Q4 2025. Quarterly EPS shifted from US$0.46 in Q3 2024 to US$0.75 in Q4 2024 and climbed through 2025 to...

Celsius Holdings (CELH) closed out FY 2025 with Q4 revenue of US$721.6 million and basic EPS of US$0.04, alongside trailing twelve month revenue of about US$2.5 billion and EPS of US$0.25. This provides a clear snapshot of where the business stands after a volatile year. The company reported quarterly revenue of US$332.2 million in Q4 2024 and US$721.6 million in Q4 2025, while EPS moved from a loss of US$0.09 to a profit of US$0.04 over the same period. This sets up a results season in which...

IDEXX Laboratories (NasdaqGS:IDXX) announced the upcoming retirement of long-serving Board member M. Anne Szostak. The company also disclosed the appointment of Michael G. Erickson, PhD, to its Board of Directors. These Board changes reflect an ongoing refresh of corporate governance and Board composition. IDEXX Laboratories focuses on diagnostic and software solutions for veterinary practices, livestock, poultry, and water testing, placing the company at the center of long term trends in...

DXP Enterprises (DXPE) has wrapped up FY 2025 with Q4 revenue of US$527.4 million and basic EPS of US$1.46, alongside net income excluding extraordinary items of US$22.8 million. On a trailing twelve month basis, revenue stands at about US$2.0 billion with EPS of US$5.65 and net income of US$88.6 million. The company has seen quarterly revenue move from US$470.9 million in Q4 2024 to US$527.4 million in Q4 2025, with basic EPS shifting from US$1.36 to US$1.46 over the same period. This puts...

In February 2026, Aspen Aerogels reported fourth-quarter 2025 sales of US$41.34 million versus US$123.09 million a year earlier, swung to a net loss of US$72.91 million, recorded an impairment charge on property, plant and equipment, and launched a broad review of options for its business and capital structure. An important insight is that management characterizes this strategic review as coming from a position of financial strength and operational progress, even as the company posts a...

LandBridge (LB) just wrapped up FY 2025 with fourth quarter revenue of US$56.8 million and basic EPS of US$0.29, while trailing twelve month EPS came in at US$1.08 on revenue of US$199.1 million, setting a clear reference point for how the business is currently earning its profits. The company has seen revenue move from US$36.5 million in Q4 2024 to US$56.8 million in Q4 2025, with quarterly EPS shifting from US$0.12 to US$0.29 over the same stretch. Those figures sit alongside trailing...

Central Securities Corporation (NYSE American: CET) has released its annual report for the year ended December 31, 2025, reporting full-year net income of US$265.21 million. The annual report gives investors a clearer view into how this closed-end investment company managed its portfolio and operations over the 2025 calendar year. We will now examine how Central Securities’ 2025 net income performance shapes the company’s investment narrative for shareholders and prospective...

Nvidia (NVDA) has put up big headline numbers for FY 2026, with fourth quarter revenue of about US$68.1b and basic EPS of US$1.77, capping a year in which trailing 12 month EPS reached US$4.93 alongside revenue of roughly US$215.9b. Over the past six quarters, the company has seen quarterly revenue move from about US$35.1b with EPS of US$0.79 in FY 2025 Q3 to US$68.1b and EPS of US$1.77 in FY 2026 Q4. This sets up a story where investors are watching how rich margins and strong earnings...

Shenandoah Telecommunications (SHEN) closed out FY 2025 with Q4 revenue of US$91.6 million and a basic EPS loss of US$0.13, as net income excluding extra items came in at a loss of US$7.3 million. The company reported quarterly revenue of US$85.4 million in Q4 2024 and US$91.6 million in Q4 2025, while basic EPS remained negative over that stretch, ranging from a loss of US$0.15 to US$0.20 per quarter. For investors, the latest results keep the focus on margins and the path back toward more...

NerdWallet (NRDS) just wrapped up FY 2025 with Q4 revenue of US$225.4 million and basic EPS of US$0.19, alongside trailing twelve month revenue of US$836.6 million and EPS of US$0.73 that underline a year of positive reported profitability. Over the past six quarters, revenue has moved from US$183.8 million in Q4 2024 to US$225.4 million in Q4 2025, while quarterly EPS ranged from roughly breakeven in early 2024 and 2025 to a high of US$0.52 in Q4 2024 and US$0.35 in Q3 2025. This sets up a...